Distribution of ACE2, CD147, CD26 and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors

U. Radzikowska, Mei Ding, Ge Tan, D. Zhakparov, Yaqi Peng, P. Wawrzyniak, Ming Wang, Shuo Li, H. Morita, C. Altunbulakli, M. Reiger, A. Neumann, N. Lunjani, C. Traidl‐Hoffmann, Kari C. Nadeau, L. O’Mahony, C. Akdis, M. Sokolowska

Allergy, 2020

Morbidity and mortality from COVID‐19 caused by novel coronavirus SARS‐CoV‐2 is accelerating worldwide, and novel clinical presentations of COVID‐19 are often reported. The range of human cells and tissues targeted by SARS‐CoV‐2, its potential receptors and associated regulating factors are still largely unknown. The aim of our study was to analyze the expression of known and potential SARS‐CoV‐2 receptors and related molecules in the extensive collection of primary human cells and tissues from healthy subjects of different age and from patients with risk factors and known comorbidities of COVID‐19.

Cited by 171 publications.

Field of study: Medicine

10.1111/all.14429